AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
43,350
+1,250 (2.97%)
At close: Dec 5, 2025
172.30%
Market Cap 1.01T
Revenue (ttm) 8.97B
Net Income (ttm) -877.63M
Shares Out 23.21M
EPS (ttm) -38.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,728,703
Average Volume 1,408,356
Open 42,650
Previous Close 42,100
Day's Range 41,400 - 46,950
52-Week Range 11,980 - 46,950
Beta 1.61
RSI 66.25
Earnings Date n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.